MFDS
- Status: likely_approved
🇰🇷 Molecule 129 in South Korea
Molecule 129 (TAGRAXOFUSP) regulatory status in South Korea.
Marketing authorisations
MFDS
- Status: likely_approved
Molecule 129 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Molecule 129 approved in South Korea?
Yes. MFDS has authorised it; MFDS has authorised it.
Who is the marketing authorisation holder for Molecule 129 in South Korea?
Stemline Therapeeutics Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.